Dolan Matthew Vincent has filed 9 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 3048 shares of DEXCOM INC ($DXCM) on January 28, 2025.
Activity breakdown: 0 open-market purchases and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2025 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP, Strategy & Corporate Dev | A | Common Stock | 3048 | $0.00 | 43,227.0000 | 412,700,000 | 7.59% | 0.00% |
| Jan. 29, 2025 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP, Strategy & Corporate Dev | S | Common Stock | 1183 | $86.91 | 42,044.0000 | 412,700,000 | 2.74% | 0.00% |
| May 15, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy and Corporate Dev | S | Common Stock | 2423 | $126.58 | 40,075.0000 | 425,500,000 | 5.70% | 0.00% |
| April 15, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy and Corporate Dev | S | Common Stock | 1990 | $137.81 | 42,377.0000 | 425,500,000 | 4.49% | 0.00% |
| March 15, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy & Corp Dev | S | Common Stock | 1886 | $129.18 | 46,684.0000 | 425,500,000 | 3.88% | 0.00% |
| March 15, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy & Corp Dev | S | Common Stock | 1314 | $130.77 | 45,370.0000 | 425,500,000 | 2.81% | 0.00% |
| March 15, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy & Corp Dev | S | Common Stock | 1003 | $131.39 | 44,367.0000 | 425,500,000 | 2.21% | 0.00% |
| March 12, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy and Corporate | S | Common Stock | 6710 | $134.41 | 48,570.0000 | 425,500,000 | 12.14% | 0.00% |
| March 8, 2024 | DEXCOM INC | $DXCM | Dolan Matthew Vincent | EVP Strategy and Corporate | A | Common Stock | 21711 | $0.00 | 55,280.0000 | 425,500,000 | 64.68% | 0.01% |